Infarnosys

About Pharmahungary

Pharmahungary Group is a unique hybrid entity combining a full-service Contract Research Organization (CRO) with an internal biotech R&D arm. Its core expertise lies in complex preclinical models, particularly in cardiovascular and metabolic diseases, and in managing niche clinical trials for medical devices and sensitive populations. The company is advancing a pipeline of diagnostic and therapeutic projects, supported by proprietary bioinformatics tools, and is led by a founder with recognized scientific excellence. Its business model generates service revenue while seeking partnership deals for its proprietary assets.

Therapeutic Areas